We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Selecting an LMS: Identifying System Requirements

Selecting an LMS: Identifying System Requirements

December 10, 2014

Perhaps the most important part of selecting a learning management system (LMS) is determining system requirements. You start by mapping the current training documentation process and testing it to make the system as efficient as possible. This must be done first to avoid transferring any current problems into the new system.

Analysis of the current system should include evaluating the quality, organization and content of the records being maintained. Every document should be identified along with its link(s) to other documents, such as SOPs, batch records, guidelines or other information that may be used in training but might not be labeled as training documents.

The next step is to outline the workflow and list desired system outcomes. A number of questions require resolution including:

  • What reports will be required?
  • What queries will be required?
  • What level of security is necessary?
  • What other databases or electronic systems will the LMS need to interact with?
  • What is needed to make the system compliant with 21 CFR Part 11?

Once these questions are answered, it’s time to dig into the details: the data the system will record. Most people agree that at least the following should be included in a "bare bones" training documentation system:

  • Who received the training;
  • Who provided the training;
  • The date training was provided and the location of the training;
  • The training program content, with course objectives, outlines or lesson plans, and assessments/tests;
  • Tests results.

After these minimum requirements have been fulfilled, additional data may need to be added, such as job information, including job description and tasks; prerequisite knowledge and skills; training requirements; SOP requirements; and training effectiveness indicators for both knowledge and skill.

Part 11 Compliance

No matter how you decide to design your LMS, one detail is critical. It must comply with the FDA’s Part 11 regulations.

Part 11 applies to all FDA program areas but does not mandate electronic recordkeeping. It describes the technical and procedural requirements that must be met if an organization chooses to maintain records electronically and use electronic signatures. It consists of two subparts.

Subpart B – Electronic Documentation requires systems to include an audit trail for all electronic records. This means that from the initial creation of a record, the system must keep a log of all changes made, the date and time of change, and the individual who made the change.

Subpart C – Electronic Signatures sets specific requirements for signing documents within the LMS. Electronic signatures must be the equivalent of hand-written signatures and include the printed name of signer, date and time of signing, and meaning of the signature (author, approver, etc.). They must be linked to the records to which they are applied and should appear whenever the record is viewed or printed.

If the LMS is used to store electronic training records, but does not include electronic signatures, then compliance is only required with Subpart B.

In next week’s issue, we’ll cover how to review available LMS programs and how to select the one that is right for your needs.

Contact Information:
Dave Gallup
GMPTraining.com, Inc.
18585 Coastal Highway
Unit 10, #149
Rehoboth, DE 19971
215-870-5665
dagallup@gmptraining.com
www.gmptraining.com

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 12Apr

    The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 26Apr

    Building the Foundation for QMS AI

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Surmodics Gets FDA’s Feedback on Rejected PMA

  • EU Approves Amicus Therapeutics Pombiliti for Late-Onset Pompe Disease

  • FDA Final Order Requires PMA for Spinal Spheres

  • FDA and Lupus Research Alliance Form Drug Development Consortium

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing